Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Hoth Therapeutics Inc (HOTH)

  • Technical Exchange News
  • June 19, 2025, 01:53 UTC
  • 31
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Caribou Biosciences Inc (CRBU)

  • Technical Exchange News
  • June 19, 2025, 01:53 UTC
  • 28
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Lipella Pharmaceuticals Inc (LIPO)

  • Technical Exchange News
  • June 18, 2025, 19:27 UTC
  • 30
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Hoth Therapeutics Inc (HOTH)

  • Technical Exchange News
  • June 18, 2025, 19:27 UTC
  • 31
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Caribou Biosciences Inc (CRBU)

  • Technical Exchange News
  • June 18, 2025, 19:26 UTC
  • 29
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

OncoCyte Corporation (OCX)

  • Technical Exchange News
  • June 18, 2025, 07:48 UTC
  • 30
  • 0 comments

OncoCyte Corporation (OCX) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

OncoCyte Corporation (OCX)

  • Technical Exchange News
  • June 18, 2025, 07:24 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Oncocyte Corporation - Common Stock.

Comment Full text

OncoCyte Corporation (OCX)

  • Technical Exchange News
  • June 18, 2025, 07:24 UTC
  • 22
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Oncocyte Corporation - Common Stock. New value: Oncocyte Corporation - Common Stock.

Comment Full text

OncoCyte Corporation (OCX)

  • Technical Exchange News
  • June 18, 2025, 07:24 UTC
  • 25
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Oncocyte Corporation - Common Stock.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • June 18, 2025, 01:48 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 66
  • 67
  • 68
  • 69
  • 70
  • Next

Search

News categories

  • Technical Exchange News(10033)
  • Event(412)
  • SEC News(169702)
  • FDA Approval(9405)
  • Company Report(721)
  • Business News(112980)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin